Literature DB >> 23903654

The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein.

Tiziana Sonati1, Regina R Reimann, Jeppe Falsig, Pravas Kumar Baral, Tracy O'Connor, Simone Hornemann, Sine Yaganoglu, Bei Li, Uli S Herrmann, Barbara Wieland, Mridula Swayampakula, Muhammad Hafizur Rahman, Dipankar Das, Nat Kav, Roland Riek, Pawel P Liberski, Michael N G James, Adriano Aguzzi.   

Abstract

Prion infections cause lethal neurodegeneration. This process requires the cellular prion protein (PrP(C); ref. 1), which contains a globular domain hinged to a long amino-proximal flexible tail. Here we describe rapid neurotoxicity in mice and cerebellar organotypic cultured slices exposed to ligands targeting the α1 and α3 helices of the PrP(C) globular domain. Ligands included seven distinct monoclonal antibodies, monovalent Fab1 fragments and recombinant single-chain variable fragment miniantibodies. Similar to prion infections, the toxicity of globular domain ligands required neuronal PrP(C), was exacerbated by PrP(C) overexpression, was associated with calpain activation and was antagonized by calpain inhibitors. Neurodegeneration was accompanied by a burst of reactive oxygen species, and was suppressed by antioxidants. Furthermore, genetic ablation of the superoxide-producing enzyme NOX2 (also known as CYBB) protected mice from globular domain ligand toxicity. We also found that neurotoxicity was prevented by deletions of the octapeptide repeats within the flexible tail. These deletions did not appreciably compromise globular domain antibody binding, suggesting that the flexible tail is required to transmit toxic signals that originate from the globular domain and trigger oxidative stress and calpain activation. Supporting this view, various octapeptide ligands were not only innocuous to both cerebellar organotypic cultured slices and mice, but also prevented the toxicity of globular domain ligands while not interfering with their binding. We conclude that PrP(C) consists of two functionally distinct modules, with the globular domain and the flexible tail exerting regulatory and executive functions, respectively. Octapeptide ligands also prolonged the life of mice expressing the toxic PrP(C) mutant, PrP(Δ94-134), indicating that the flexible tail mediates toxicity in two distinct PrP(C)-related conditions. Flexible tail-mediated toxicity may conceivably play a role in further prion pathologies, such as familial Creutzfeldt-Jakob disease in humans bearing supernumerary octapeptides.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23903654     DOI: 10.1038/nature12402

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  50 in total

1.  Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice.

Authors:  E Flechsig; D Shmerling; I Hegyi; A J Raeber; M Fischer; A Cozzio; C von Mering; A Aguzzi; C Weissmann
Journal:  Neuron       Date:  2000-08       Impact factor: 17.173

2.  Prion disease with octapeptide repeat insertion.

Authors:  C Vital; F Gray; A Vital; X Ferrer; J Julien
Journal:  Clin Exp Pathol       Date:  1999

3.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

4.  Prion protein library of recombinant constructs for structural biology.

Authors:  Simone Hornemann; Barbara Christen; Christine von Schroetter; Daniel R Pérez; Kurt Wüthrich
Journal:  FEBS J       Date:  2009-04       Impact factor: 5.542

5.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

Review 6.  Oxidative stress in neurodegeneration and available means of protection.

Authors:  Amos Akintayo Fatokun; Trevor William Stone; Robert Anthony Smith
Journal:  Front Biosci       Date:  2008-05-01

7.  Prion protein interaction with the C-terminal SH3 domain of Grb2 studied using NMR and optical spectroscopy.

Authors:  Dominikus A Lysek; Kurt Wüthrich
Journal:  Biochemistry       Date:  2004-08-17       Impact factor: 3.162

8.  Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

Authors:  M Fischer; T Rülicke; A Raeber; A Sailer; M Moser; B Oesch; S Brandner; A Aguzzi; C Weissmann
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Biological and biochemical characterization of mice expressing prion protein devoid of the octapeptide repeat region after infection with prions.

Authors:  Yoshitaka Yamaguchi; Hironori Miyata; Keiji Uchiyama; Akira Ootsuyama; Sachiko Inubushi; Tsuyoshi Mori; Naomi Muramatsu; Shigeru Katamine; Suehiro Sakaguchi
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

View more
  95 in total

1.  In vitro neutralization of prions with PrP(Sc)-specific antibodies.

Authors:  Ryan Taschuk; Jacques Van der Merwe; Kristen Marciniuk; Andrew Potter; Neil Cashman; Philip Griebel; Scott Napper
Journal:  Prion       Date:  2015       Impact factor: 3.931

2.  PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.

Authors:  Pekka Määttänen; Ryan Taschuk; Li Ross; Kristen Marciniuk; Lisa Bertram; Andrew Potter; Neil R Cashman; Scott Napper
Journal:  Prion       Date:  2013-10-08       Impact factor: 3.931

3.  Both N-Terminal and C-Terminal Histidine Residues of the Prion Protein Are Essential for Copper Coordination and Neuroprotective Self-Regulation.

Authors:  Kevin M Schilling; Lizhi Tao; Bei Wu; Joseph T M Kiblen; Natalia C Ubilla-Rodriguez; M Jake Pushie; R David Britt; Graham P Roseman; David A Harris; Glenn L Millhauser
Journal:  J Mol Biol       Date:  2020-05-28       Impact factor: 5.469

4.  MEK1 transduces the prion protein N2 fragment antioxidant effects.

Authors:  C L Haigh; A R McGlade; S J Collins
Journal:  Cell Mol Life Sci       Date:  2014-11-13       Impact factor: 9.261

5.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

6.  Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay.

Authors:  Boris A Ballmer; Rita Moos; Prisca Liberali; Lucas Pelkmans; Simone Hornemann; Adriano Aguzzi
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

7.  Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.

Authors:  Erik C Gunther; Levi M Smith; Mikhail A Kostylev; Timothy O Cox; Adam C Kaufman; Suho Lee; Ewa Folta-Stogniew; George D Maynard; Ji Won Um; Massimiliano Stagi; Jacqueline K Heiss; Austin Stoner; Geoff P Noble; Hideyuki Takahashi; Laura T Haas; John S Schneekloth; Janie Merkel; Christopher Teran; Zahra K Naderi; Surachai Supattapone; Stephen M Strittmatter
Journal:  Cell Rep       Date:  2019-01-02       Impact factor: 9.423

8.  Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.

Authors:  Flavio H Beraldo; Valeriy G Ostapchenko; Fabiana A Caetano; Andre L S Guimaraes; Giulia D S Ferretti; Nathalie Daude; Lisa Bertram; Katiane O P C Nogueira; Jerson L Silva; David Westaway; Neil R Cashman; Vilma R Martins; Vania F Prado; Marco A M Prado
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

9.  Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease.

Authors:  Dilshan S Harischandra; Naveen Kondru; Dustin P Martin; Arthi Kanthasamy; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

10.  Domain-Specific Activation of Death-Associated Intracellular Signalling Cascades by the Cellular Prion Protein in Neuroblastoma Cells.

Authors:  Silvia Vilches; Cristina Vergara; Oriol Nicolás; Ágata Mata; José A Del Río; Rosalina Gavín
Journal:  Mol Neurobiol       Date:  2015-08-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.